State Medicaid Outpatient Drug Utilization and Reimbursements

State Drug Utilization Data contains records of covered outpatient drugs paid for by state Medicaid agencies under the Medicaid Drug Rebate Program. The data likely includes state, drug name, National Drug Code (NDC), number of prescriptions, and dollars reimbursed. It is reported by states and serves as a source for analyzing drug spending and utilization patterns within the Medicaid program.

Use Cases

• Analyzing state-level prescription volume trends based on drug name and prescription counts.
• Comparing Medicaid reimbursement amounts across states for specific drugs using the National Drug Code.
• Monitoring the utilization of covered outpatient drugs within the Medicaid program over time.

Strengths

• Data is reported by state Medicaid agencies, providing an official administrative source.
• Covers the period since the start of the Medicaid Drug Rebate Program, offering a long-term perspective.

Limitations

• Key metadata such as row count, file size, and specific column names are not provided in the source descriptions.
• Conflicting license information is present ('other-license-specified' and 'us-pd'), creating ambiguity for reuse.

Provenance

Source

U.S. Department of Health & Human Services, reported by state Medicaid agencies.

Collection Method

Reported by states for covered outpatient drugs paid for under the Medicaid Drug Rebate Program.

Time Range

Since the start of the Medicaid Drug Rebate Program.

Freshness

Last updated on 2026-04-08 according to multiple platform entries.

Geography

United States, reported at the state level.